Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. Juli 2024 16:05 ET | Quelle: TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc. Announces Closing of Public Offering

Boston, MA — July 24, 2024 — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to
22. Juli 2024 22:30 ET | Quelle: TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc. Announces Pricing of Public Offering

Boston, MA — July 22, 2024 — TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed t
10. Juni 2024 07:00 ET | Quelle: TransCode Therapeutics, Inc.

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
22. Januar 2024 16:45 ET | Quelle: TransCode Therapeutics, Inc.

TransCode Therapeutics Announces Closing of $7.25 Million Public Offering

TransCode Therapeutics closes public offering
06. Januar 2022 15:17 ET | Quelle: TransCode Therapeutics, Inc.

TransCode Therapeutics To Participate at H.C. Wainwright BioConnect Conference

BOSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and presenting at the H.C. Wainwright BioConnect Conference....